Video Experimental Relacionado
Updated: Jun 25, 2026
08:08
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Fisiopatología del ejercicio en pacientes con hipertensión pulmonar primaria
X G Sun1, J E Hansen, R J Oudiz
1Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
Circulation
|July 27, 2001
Resumen
La prueba de ejercicio cardiopulmonar (CPET) evalúa con seguridad la limitación del ejercicio en pacientes con hipertensión pulmonar primaria (HPP). Los hallazgos del CPET son característicos y se correlacionan bien con la gravedad de los síntomas, lo que ayuda a comprender la HPP.
Área de la Ciencia:
- Cardiología Cardiología.
- Pulmonología Pulmonología.
- Fisiología del ejercicio Fisiología del ejercicio
Sus antecedentes:
- La hipertensión pulmonar primaria (HPP) implica vasculopatía pulmonar que causa intolerancia al ejercicio.
- La disnea y la fatiga son síntomas comunes que limitan las actividades diarias en pacientes con HPP.
Objetivo del estudio:
- Investigar la base de la limitación del ejercicio en pacientes con PPH.
- Evaluar la utilidad de la prueba de ejercicio cardiopulmonar (CPET) en PPH.
Principales métodos:
- Evaluación retrospectiva de 53 pacientes PPH sometidos a cateterismo cardíaco derecho y ergómetro de ciclo CPET.
- Análisis del intercambio de gases, la clase de síntomas de la Asociación del Corazón de Nueva York (NYHA) y la hemodinámica pulmonar en reposo.
Principales resultados:
- El CPET reveló reducciones consistentes en el pico de absorción de oxígeno (VO2), el umbral anaeróbico y la eficiencia ventilatoria.
- La clase NYHA se correlacionó fuertemente con la función aeróbica y los parámetros de eficiencia ventilatoria de CPET.
- CPET fue tolerado con seguridad por todos los pacientes a la capacidad máxima.
Conclusiones:
- El ergómetro de ciclo no invasivo CPET es una herramienta segura y valiosa para los pacientes con HPP.
- Las anomalías del CPET son características de PPH y se correlacionan bien con la clasificación de síntomas clínicos (NYHA).
Videos de Conceptos Relacionados
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...